A
$ Value
$0
Shares
84,925
Price
$0
Filed
Nov 6
Insider
Name
Khan Najat
Title
Chief R&D Commercial Officer
CIK
0002020969
Roles
Director
Officer
Transaction Details
Transaction Date
2025-11-05
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
753,122
Footnotes
This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on February 15, 2026, and every three months thereafter. | The option vests as to one forty-eighth (1/48th) of the shares subject to the option on December 5, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
Filing Info
Khan Najat's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-22 | RXRX | ▼ | $549K |
| 2025-11-17 | RXRX | F | $73K |
| 2025-11-05 | RXRX | A | $0 |
| 2025-11-05 | RXRX | A | $0 |
| 2025-08-18 | RXRX | ▼ | $202K |
| 2025-08-15 | RXRX | F | $21K |
| 2025-05-15 | RXRX | F | $16K |
Other Insiders at RXRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Taylor Ben R
Chief Financial Officer
|
— | — | 2026-04-06 |
| Li Dean Y | — | — | 2026-04-01 |
| Dar Zavain | — | — | 2026-04-01 |
| Borgeson Blake | — | $1.0M | 2026-04-07 |
| Gibson Christopher | — | $419K | 2026-04-07 |